SEARCH

SEARCH BY CITATION

References

  1. References
  2. References
  • 1
    Primignani M, Andreoni B, Carpinelli L, Capria A, Rocchi G, Lorenzini I, Staudacher C. et al. Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: a randomized, double-blind, placebo-controlled, multicenter trial. Hepatology 1995; 21: 13221327.
  • 2
    Silvain C, Carpentier S, Sautereau D, Czernichow B, Métreau JM, Fort E, Ingrand P. et al. Terlipressin plus transdermal nitro-glycerin versus octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial. Hepatology 1993; 18: 6165.
  • 3
    Albillos A, Rossi I, Iborra J, Lledo JL, Calleja JL, Barrios C, Garcia P. et al. Octreotide prevents postprandial splanchnic hy-peremia in patients with portal hypertension. J Hepatol 1994; 21: 8894.
  • 4
    Navasa M, Bosch J, Chesta J, Bru C, Pizcueta P, Garcia Pagan JC. et al. Haemodynamic effects of subcutaneous administration of SMS 201-995, a long acting somatostatin analog, in patients with cirrhosis and portal hypertension J Hepatol 1988; 7(suppl): S64. Abstract.

References

  1. References
  2. References
  • 1
    Silvain C, Carpenter S, Satereau D, Czernichow B, Metreau JM, Fort E, Ingrand P. et al. Terlipressin plus transdermal nitroglycerin versus octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial. Hepatology 1993; 18: 6165.
  • 2
    Pedretti G, Elia S, Calzetti C, Magnani G, Fiaccadori F. Octreotide versus terlipressin in acute variceal hemorrhage in liver cirrhosis. Emergency control and prevention of early re-bleeding. Clin Invest 1994; 72: 653659.
  • 3
    Hwang SJ, Lin HC, Chang CF, Lee FJ, Lu CW, Hsia HC, Wang SS. et al. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal bleeding. J Hepatol 1992; 16: 320325.
  • 4
    McCormick PA, Chin J, Greenslade L, Karatapanis S, Dick R, McLntyre N, Burrought AK. Cardiovascular effects of octreotide in patients with hepatic cirrhosis. Hepatology 1995; 21: 12551260.
  • 5
    Primignani M, Carpinelli L, Vazzoler MC, De Lima MCH, Nolte A, Marcelli R, De Franchis R. Short term effect of octreotide on intraesophageal variceal pressure: a double blind placebo controlled study. Eur J Gastroenterol Hepatol 1994; 6: 10271031.